Price T Rowe Associates Inc Novartis Ag Transaction History

Price T Rowe Associates Inc

  • $812 Billion
  • Q1 2025

A detailed history of Price T Rowe Associates Inc transactions in Novartis Ag stock. As of the latest transaction made, Price T Rowe Associates Inc holds 52,648 shares of NVS stock, worth $6.09 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
52,648
Previous 73,888 28.75%
Holding current value
$6.09 Million
Previous $7.19 Million 18.37%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
SELL
$97.14 - $115.57 $2.06 Million - $2.45 Million
-21,240 Reduced 28.75%
52,648 $5.87 Million
Q4 2024

Feb 14, 2025
SELL
$96.78 - $117.18 $4.53 Million - $5.49 Million
-46,833 Reduced 38.79%
73,888 $7.19 Million
Q3 2024

Nov 14, 2024
BUY
$106.13 - $120.89 $12.1 Million - $13.7 Million
113,634 Added 1603.41%
120,721 $13.9 Million
Q2 2024

Aug 14, 2024
SELL
$92.57 - $107.37 $10.1 Million - $11.7 Million
-108,762 Reduced 93.88%
7,087 $755,000
Q1 2024

May 15, 2024
BUY
$95.27 - $108.47 $352,117 - $400,905
3,696 Added 3.3%
115,849 $11.2 Million
Q4 2023

Feb 14, 2024
SELL
$92.27 - $101.54 $116,352 - $128,041
-1,261 Reduced 1.11%
112,153 $11.3 Million
Q3 2023

Nov 14, 2023
BUY
$94.73 - $105.13 $638,290 - $708,365
6,738 Added 6.32%
113,414 $11.6 Million
Q2 2023

Aug 14, 2023
BUY
$92.52 - $104.91 $848,778 - $962,444
9,174 Added 9.41%
106,676 $10.8 Million
Q1 2023

May 15, 2023
BUY
$80.03 - $92.81 $293,950 - $340,891
3,673 Added 3.91%
97,502 $8.97 Million
Q4 2022

Feb 14, 2023
SELL
$75.55 - $92.52 $58,475 - $71,610
-774 Reduced 0.82%
93,829 $8.51 Million
Q3 2022

Nov 14, 2022
BUY
$74.61 - $87.26 $3.97 Million - $4.64 Million
53,220 Added 128.6%
94,603 $13.3 Million
Q2 2022

Aug 15, 2022
BUY
$80.52 - $93.75 $151,458 - $176,343
1,881 Added 4.76%
41,383 $3.5 Million
Q1 2022

May 16, 2022
BUY
$80.11 - $90.62 $424,022 - $479,651
5,293 Added 15.47%
39,502 $3.47 Million
Q4 2021

Feb 14, 2022
BUY
$79.7 - $88.13 $70,933 - $78,435
890 Added 2.67%
34,209 $2.99 Million
Q3 2021

Nov 15, 2021
BUY
$81.78 - $95.14 $220,069 - $256,021
2,691 Added 8.79%
33,319 $2.72 Million
Q2 2021

Aug 16, 2021
BUY
$85.24 - $94.15 $261,090 - $288,381
3,063 Added 11.11%
30,628 $2.79 Million
Q1 2021

May 17, 2021
SELL
$83.5 - $98.47 $56,028 - $66,073
-671 Reduced 2.38%
27,565 $2.36 Million
Q4 2020

Feb 16, 2021
BUY
$78.07 - $94.43 $2.2 Million - $2.67 Million
28,236 New
28,236 $2.08 Million

Others Institutions Holding NVS

# of Institutions
1,524
Shares Held
142M
Call Options Held
1.63M
Put Options Held
1.82M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $249B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email